chr21-32467842-C-G
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_058187.5(EVA1C):āc.628C>Gā(p.Pro210Ala) variant causes a missense change. The variant allele was found at a frequency of 0.000165 in 1,607,910 control chromosomes in the GnomAD database, including 4 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. P210R) has been classified as Uncertain significance.
Frequency
Consequence
NM_058187.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
EVA1C | NM_058187.5 | c.628C>G | p.Pro210Ala | missense_variant | 4/8 | ENST00000300255.7 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
EVA1C | ENST00000300255.7 | c.628C>G | p.Pro210Ala | missense_variant | 4/8 | 1 | NM_058187.5 | P3 |
Frequencies
GnomAD3 genomes AF: 0.0000725 AC: 11AN: 151822Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.000361 AC: 88AN: 244102Hom.: 0 AF XY: 0.000378 AC XY: 50AN XY: 132216
GnomAD4 exome AF: 0.000174 AC: 254AN: 1455970Hom.: 4 Cov.: 32 AF XY: 0.000214 AC XY: 155AN XY: 724330
GnomAD4 genome AF: 0.0000724 AC: 11AN: 151940Hom.: 0 Cov.: 31 AF XY: 0.0000539 AC XY: 4AN XY: 74280
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 20, 2021 | The c.628C>G (p.P210A) alteration is located in exon 4 (coding exon 4) of the EVA1C gene. This alteration results from a C to G substitution at nucleotide position 628, causing the proline (P) at amino acid position 210 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at